Effect of Low-dose PegIntron on ALT Normalization in Japanese Patients With Chronic Hepatitis C (Study P04508)(COMPLETED)

NCT00787371 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

69

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C, Chronic
Hepatitis C

Interventions

BIOLOGICAL: PegIntron (peginterferon alfa-2b)
BIOLOGICAL: PegIntron (peginterferon alfa-2b)
BIOLOGICAL: PegIntron (peginterferon alfa-2b)

Sponsor

Merck Sharp & Dohme LLC